Ye Bin, Kroboth Stacie L, Pu Jie-Lin, Sims Jason J, Aggarwal Nitin T, McNally Elizabeth M, Makielski Jonathan C, Shi Nian-Qing
Department of Medicine, University of Wisconsin, Madison, WI 53706, USA.
Circ Res. 2009 Nov 20;105(11):1083-93. doi: 10.1161/CIRCRESAHA.109.195040. Epub 2009 Oct 1.
Cardioprotective pathways may involve a mitochondrial ATP-sensitive potassium (mitoK(ATP)) channel but its composition is not fully understood.
We hypothesized that the mitoK(ATP) channel contains a sulfonylurea receptor (SUR)2 regulatory subunit and aimed to identify the molecular structure.
Western blot analysis in cardiac mitochondria detected a 55-kDa mitochondrial SUR2 (mitoSUR2) short form, 2 additional short forms (28 and 68 kDa), and a 130-kDa long form. RACE (Rapid Amplification of cDNA Ends) identified a 1.5-Kb transcript, which was generated by a nonconventional intraexonic splicing (IES) event within the 4th and 29th exons of the SUR2 mRNA. The translated product matched the predicted size of the 55-kDa short form. In a knockout mouse (SUR2KO), in which the SUR2 gene was disrupted, the 130-kDa mitoSUR2 was absent, but the short forms remained expressed. Diazoxide failed to induce increased fluorescence of flavoprotein oxidation in SUR2KO cells, indicating that the diazoxide-sensitive mitoK(ATP) channel activity was associated with 130-kDa-based channels. However, SUR2KO mice displayed similar infarct sizes to preconditioned wild type, suggesting a protective role for the remaining short form-based channels. Heterologous coexpression of the SUR2 IES variant and Kir6.2 in a K(+) transport mutant Escherichia coli strain permitted improved cell growth under acidic pH conditions. The SUR2 IES variant was localized to mitochondria, and removal of a predicted mitochondrial targeting sequence allowed surface expression and detection of an ATP-sensitive current when coexpressed with Kir6.2.
We identify a novel SUR2 IES variant in cardiac mitochondria and provide evidence that the variant-based channel can form an ATP-sensitive conductance and may contribute to cardioprotection.
心脏保护途径可能涉及线粒体ATP敏感性钾通道(mitoK(ATP)),但其组成尚未完全明确。
我们推测mitoK(ATP)通道包含磺脲类受体(SUR)2调节亚基,并旨在确定其分子结构。
对心脏线粒体进行蛋白质免疫印迹分析,检测到一种55 kDa的线粒体SUR2(mitoSUR2)短形式、另外两种短形式(28 kDa和68 kDa)以及一种130 kDa的长形式。cDNA末端快速扩增(RACE)鉴定出一个1.5 kb的转录本,它是由SUR2 mRNA第4和第29外显子内的非常规外显子内剪接(IES)事件产生的。翻译产物与预测的55 kDa短形式大小相符。在SUR2基因被破坏的基因敲除小鼠(SUR2KO)中,130 kDa的mitoSUR2不存在,但短形式仍有表达。二氮嗪未能诱导SUR2KO细胞中黄素蛋白氧化荧光增加,表明二氮嗪敏感的mitoK(ATP)通道活性与基于130 kDa的通道相关。然而,SUR2KO小鼠的梗死面积与预处理的野生型相似,提示剩余的基于短形式的通道具有保护作用。SUR2 IES变体与Kir6.2在K(+)转运突变大肠杆菌菌株中的异源共表达,使得在酸性pH条件下细胞生长得到改善。SUR2 IES变体定位于线粒体,去除预测的线粒体靶向序列后,与Kir6.2共表达时可实现表面表达并检测到ATP敏感性电流。
我们在心脏线粒体中鉴定出一种新型的SUR2 IES变体,并提供证据表明基于该变体的通道可形成ATP敏感性电导,可能有助于心脏保护。